Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.

Literature DB >> 23868334

Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.

Paolo Zanotti-Fregonara¹, Adriaan A Lammertsma, Robert B Innis.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2013 PMID： 23868334 PMCID： PMC3844925 DOI： 10.1007/s00259-013-2512-x

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

× No keyword cloud information.

19 in total

1. 18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies.

Authors: Tuula Tolvanen; Kaisa Lehtiö; Jarmo Kulmala; Vesa Oikonen; Olli Eskola; Jörgen Bergman; Heikki Minn
Journal: J Nucl Med Date: 2002-12 Impact factor: 10.057

2. Radiological Protection in Biomedical Research. A report of Committee 3 adopted by the International Commission on Radiological Protection.

Authors:
Journal: Ann ICRP Date: 1991

3. Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers.

Authors: Michel Bottlaender; Héric Valette; Dimitri Roumenov; Frédéric Dollé; Christine Coulon; Michèle Ottaviani; Françoise Hinnen; Marcel Ricard
Journal: J Nucl Med Date: 2003-04 Impact factor: 10.057

4. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.

Authors: Sebastian L Obrzut; Andrei O Koren; Mark A Mandelkern; Arthur L Brody; Carl K Hoh; Edythe D London
Journal: Nucl Med Biol Date: 2005-11 Impact factor: 2.408

5. Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression.

Authors: S Yaghoubi; J R Barrio; M Dahlbom; M Iyer; M Namavari; N Satyamurthy; R Goldman; H R Herschman; M E Phelps; S S Gambhir
Journal: J Nucl Med Date: 2001-08 Impact factor: 10.057

6. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.

Authors: Jean-Mathieu Beauregard; Etienne Croteau; Naseem Ahmed; Johan E van Lier; François Bénard
Journal: J Nucl Med Date: 2008-12-17 Impact factor: 10.057

7. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.

Authors: Hubert Vesselle; John Grierson; Lanell M Peterson; Mark Muzi; David A Mankoff; Kenneth A Krohn
Journal: J Nucl Med Date: 2003-09 Impact factor: 10.057

8. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.

Authors: H M Deloar; T Fujiwara; M Shidahara; T Nakamura; H Watabe; Y Narita; M Itoh; M Miyake; S Watanuki
Journal: Eur J Nucl Med Date: 1998-06

9. 2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans.

Authors: Alane S Kimes; Andrew G Horti; Edythe D London; Svetlana I Chefer; Carlo Contoreggi; Monique Ernst; Phyllis Friello; Andrei O Koren; Varughese Kurian; John A Matochik; Olga Pavlova; D Bruce Vaupel; Alexey G Mukhin
Journal: FASEB J Date: 2003-05-20 Impact factor: 5.191

10. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.

Authors: Kamilla Smolarz; Bernd Joachim Krause; Frank-Philipp Graner; Franziska Martina Wagner; Christina Hultsch; Claudia Bacher-Stier; Richard B Sparks; Susan Ramsay; Lüder M Fels; Ludger M Dinkelborg; Markus Schwaiger
Journal: J Nucl Med Date: 2013-04-08 Impact factor: 10.057

20 in total

1. Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse.

Authors: Soumen Paul; Mohammad B Haskali; Jeih-San Liow; Sami S Zoghbi; Vanessa N Barth; Marcy Comly Kolodrubetz; Michelle R Bond; Cheryl L Morse; Robert L Gladding; Michael P Frankland; Nancy Kant; Lawrence Slieker; Sergey Shcherbinin; Hugh N Nuthall; Paolo Zanotti-Fregonara; John A Hanover; Cynthia Jesudason; Victor W Pike; Robert B Innis
Journal: J Nucl Med Date: 2018-09-13 Impact factor: 10.057

2. The PET Radioligand 18F-FIMX Images and Quantifies Metabotropic Glutamate Receptor 1 in Proportion to the Regional Density of Its Gene Transcript in Human Brain.

Authors: Paolo Zanotti-Fregonara; Rong Xu; Sami S Zoghbi; Jeih-San Liow; Masahiro Fujita; Mattia Veronese; Robert L Gladding; Denise Rallis-Frutos; Jinsoo Hong; Victor W Pike; Robert B Innis
Journal: J Nucl Med Date: 2015-10-29 Impact factor: 10.057

3. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.

Authors: Sjoerd J Finnema; Vladimir Stepanov; Ryuji Nakao; Anna W Sromek; Tangzhi Zhang; John L Neumeyer; Susan R George; Philip Seeman; Michael G Stabin; Cathrine Jonsson; Lars Farde; Christer Halldin
Journal: J Nucl Med Date: 2014-05-01 Impact factor: 10.057

4. Preclinical Safety Evaluation and Human Dosimetry of [¹⁸F]MK-6240, a Novel PET Tracer for Imaging Neurofibrillary Tangles.

Authors: Michel Koole; Talakad G Lohith; John L Valentine; Idriss Bennacef; Ruben Declercq; Tom Reynders; Kerry Riffel; Sofie Celen; Kim Serdons; Guy Bormans; Sandrine Ferry-Martin; Philippe Laroque; Abbas Walji; Eric D Hostetler; Richard J Briscoe; Jan de Hoon; Cyrille Sur; Koen Van Laere; Arie Struyk
Journal: Mol Imaging Biol Date: 2020-02 Impact factor: 3.488

Review 10. Why are we failing to implement imaging studies with radiolabelled new molecular entities in early oncology drug development?

Authors: Azeem Saleem; Philip Murphy; Christophe Plisson; Michael Lahn
Journal: ScientificWorldJournal Date: 2014-08-18